Terence Flynn
Showing 1–2 of 2 transcripts.
- Goldman Sachs26 min
The Delta Variant: Implications for Vaccines, Booster Shots and Economic Growth
Terence Flynn, Daan Struyven, Allison Nathan
Global discussions on the Delta variant highlight its heightened transmissibility and the robust protection of mRNA vaccines against severe disease, even as efficacy against mild symptomatic infection varies by region. Industry strategies are shifting toward booster programs for high-risk populations and the development of multivalent vaccines to address waning immunity and emerging threats. Concurrently, economic forecasts have been revised downward due to persistent case spikes in specific regions, supply chain bottlenecks, and consumer risk aversion slowing recovery in the United States and Asia-Pacific.
- Goldman Sachs1h 4m
Dr. Michael Mina of the Harvard T.H. Chan School of Public Health
Michael Mina, Salveen Richter, Terence Flynn, Solving Richter
Dr. Mina outlines the novel coronavirus as a highly transmissible pathogen with reduced virulence that threatens global pandemic spread through widespread asymptomatic transmission and unstable immunity patterns. Current U.S. diagnostics face critical supply chain bottlenecks that necessitate triage-based testing, while therapeutic strategies rely on supportive care and experimental antivirals like Remdesivir alongside accelerating vaccine development. The speaker predicts that aggressive social distancing can suppress transmission to protect healthcare capacity, though long-term management will likely require balancing economic needs with endemic cycles rather than aiming for total eradication.